Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-04

Clinical Trial Update: Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing polyhexamethylene biguanide to chlorhexidine as the antiseptic regimen after surgical treatment of HPV-related cervical lesions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine (chlorhexidine)
  • Polyhexamethylene Biguanide (polyhexamethylene biguanide)

Snippet

Sponsor: AGUNCO Obstetrics and Gynecology Centre | Conditions: Antisepsis Regimen After Surgical Treatment of HPV Infected Lesions | Phase 4 | Status: COMPLETED